The ESMO Congress is a highly influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.

ESMO 2023 has released its latest data, provided high quality training and excellent networking opportunities for oncologists and other stakeholders from all around the world.

Actero company participated in this event along with a number of oncology specialists to play its role in improving the level of knowledge and awareness of new cancer treatment methods.